CAMBRIDGE HEART CH 2000 CARDIAC DIAGNOSTIC SYSTEM
A Cardiac Diagnostic System Related Image
(Not Necessarily related to the device)Description:
CAMBRIDGE HEART CH 2000 CARDIAC DIAGNOSTIC SYSTEM by CAMBRIDGE HEART INC.
The Cambridge Heart CH 2000 Cardiac Diagnostic System is a state-of-the-art medical device developed by Cambridge Heart Inc., a renowned company in the medical equipment manufacturing industry. This device is primarily designed to evaluate and monitor diagnostic parameters related to the human cardiovascular system, providing data vital in the early detection and treatment of cardiovascular diseases.
One of the main benefits of utilizing the CH 2000 is its exceptional precision and dependability in cardiac assessment. It delivers high-definition heartbeat monitoring, affording the medical team with accurate and consistent data, vital for making informed diagnostic decisions. This device significantly aids in the early detection of conditions such as arrhythmia, ischemia, and heart disease, thereby ensuring timely treatment and potentially avoiding severe health consequences.
Moreover, the CH 2000 Cardiac Diagnostic System is noted for its user-friendly interface and easy integration into existing medical systems. This ensures a smooth workflow and streamlines the management of cardiac health data. Given its robust design and intuitive nature, it is a preferred choice in leading healthcare facilities globally.
In a nutshell, Cambridge Heart's CH 2000 is not just a medical device, but a comprehensive solution for cardiac diagnostics. Its advance technology, accuracy, and user-friendliness make it a reliable partner in combating cardiovascular diseases, contributing significantly to enhancing patient care and health outcomes.
Primary Use:
The CAMBRIDGE HEART CH 2000 Cardiac Diagnostic System primarily serves as an advanced tool for diagnosing heart diseases. It is specifically intended for the detection of microvolt level T-wave alternans (TWA), a condition that strongly indicates an augmented probability for critical cardiac events, especially sudden cardiac arrest. By facilitating the identification of patients at a high risk of life-threatening arrhythmias, this device proves especially vital in preventing severe cardiac events and directing patient-tailored therapeutic strategies. Critical appreciation for its functionality spans across health communities, making it a key device in the category of Cardiology Diagnostics and Monitoring Devices.
How It Works:
Introduction
The Cambridge Heart CH 2000 Cardiac Diagnostic System is a state-of-the-art device in the category of Cardiology Diagnostics and Monitoring Devices. This high-tech health tool aids clinicians in identifying patients at risk for sudden cardiac arrest, one of the leading causes of death worldwide.Detection Mechanism
The Cambridge Heart CH 2000 system uses a unique approach, known as Microvolt T-Wave Alternans (MTWA) technology, to detect potentially fatal heart rhythms. MTWA is a sophisticated measurement of microvolt-level fluctuations in the T-wave segment of a patient's heart's electrical cycle. These fluctuations have been linked to an increased risk of deadly arrhythmias that can trigger sudden cardiac arrest.Process
The patient receives a typical exercise stress test while connected to the CH 2000 system. The process involves placing adhesive electrodes on the patient's chest, akin to an EKG test.The device records heart rhythms during the test and feeds this data into its unique software. A computer algorithm then intricately analyzes these rhythms for evidence of T-wave alternans.
To ensure accuracy, the system controls for heart rate variability and noise, which can sometimes interfere with the detection of T-wave alternans.
Analysis and Results
Post-test, the system provides a unique score that ranges from negative to positive, indicating the level of risk. It does so by determining the statistical likelihood that T-wave alternans are present in a patient's EKG data.A "negative" result means T-wave alternans were not detected, suggesting lower risk. A "positive" score indicates the presence of notable T-wave alternans, suggesting a higher risk of life-threatening arrhythmias.
This allows physicians to make informed decisions about the need for further intervention, medication, or procedures such as the installation of a defibrillator. In summary, the Cambridge Heart CH 2000 Cardiac Diagnostic System embodies a groundbreaking approach to cardiac risk stratification, offering invaluable information to aid in clinical decision making. Using this tool, clinicians can potentially prevent sudden cardiac arrest, one of the often unpredictable and deadly occurrences in heart disease.
Manufacturer:
CAMBRIDGE HEART INC.
Status: In Stock
Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.